A Study on the Safety and Efficacy of Tirzepatide in People with Type 2 Diabetes
Not Applicable
Recruiting
- Conditions
- Type 2 Diabetes
- Registration Number
- JPRN-UMIN000052214
- Lead Sponsor
- Kitasato University
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 50
Inclusion Criteria
Not provided
Exclusion Criteria
1. Individuals with severe anemia (Hb < 10g/dL) 2. Patinets with implanted medical devices (such as pacemakers) 3. Patients with active malignant tumors 4. Participants for whom the Principal Investigator or Sub-Investigator has determined are not suitable for participation in this clinical study.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method The Percentage of Time within Target Glucose Range by Continuous Glucose Monitoring.
- Secondary Outcome Measures
Name Time Method
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
What are the molecular mechanisms by which Tirzepatide improves glycemic control in Type 2 Diabetes patients?
How does Tirzepatide compare to GLP-1 receptor agonists in managing Type 2 Diabetes outcomes?
Which biomarkers correlate with Tirzepatide efficacy in Japanese Type 2 Diabetes populations?
What adverse events are associated with Tirzepatide in Type 2 Diabetes clinical trials?
What are the potential synergies between Tirzepatide and SGLT2 inhibitors in diabetes treatment?